MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 04.11.2025
Heron Therapeutics ROE 2011-2026 | HRTX
ROE Jährlich Heron Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 40.36 | 325.43 | -1341.17 | -284.5 | -96.1 | -50.7 | -48.31 | -150.59 | 814.75 | -82.63 | -121.1 | -80.18 | -45.06 | -75.0 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 814.75 | -1341.17 | -85.34 |
ROE Vierteljährlich Heron Therapeutics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -105.94 | 35.93 | 36.56 | 135.82 | 230.77 | 493.13 | 297.1 | 20.43 | 172.65 | -194.05 | -238.15 | -95.57 | -392.97 | -109.02 | -135.35 | -115.88 | -101.11 | -96.1 | -84.11 | -67.81 | -56.91 | -50.7 | -49.75 | -51.79 | -49.8 | -48.31 | -82.58 | -104.14 | -126.34 | -150.59 | 122.76 | 382.95 | 618.99 | 814.75 | 562.6 | 315.14 | 92.17 | -82.63 | -88.88 | -100.12 | -110.7 | -121.1 | -108.76 | -97.0 | -89.21 | -80.18 | -74.75 | -67.89 | -54.35 | -60.56 | -72.68 | -87.54 | -90.99 | -75.0 | -26.68 | -12.27 | -9.01 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 814.75 | -392.97 | 5.52 |
ROE anderer Aktien in der Pharmaeinzelhändler
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M |  Germany |
 |
Aclaris Therapeutics
ACRS
|
-84.9 | $ 2.63 | -2.05 % | $ 203 M |  USA |
 |
AgeX Therapeutics
AGE
|
-270.67 | - | -10.17 % | $ 12.2 K | USA |
 |
Albireo Pharma
ALBO
|
-19.38 | - | -0.23 % | $ 916 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-32.19 | - | - | $ 2.17 B | USA |
 |
AlloVir
ALVR
|
-51.87 | - | 4.14 % | $ 49.1 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | USA |
 |
Ascendis Pharma A/S
ASND
|
-43.41 | $ 211.71 | -0.74 % | $ 5 B |  Danmark |
 |
Alterity Therapeutics Limited
ATHE
|
-36.22 | $ 3.27 | 1.87 % | $ 7.87 B |  Australia |
 |
Autolus Therapeutics plc
AUTL
|
-51.64 | $ 1.89 | -3.08 % | $ 482 M |  Britain |
 |
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M |  France |
 |
Aeglea BioTherapeutics
AGLE
|
-40.17 | - | - | $ 1.01 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-256.9 | - | -11.43 % | $ 502 K | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | USA |
 |
Applied Molecular Transport
AMTI
|
-207.64 | - | - | $ 10.1 M | USA |
 |
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M | Britain |
 |
Aravive
ARAV
|
-716.17 | - | -13.39 % | $ 1.45 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
-91.56 | - | -6.81 % | $ 3.04 B | USA |
 |
Athersys
ATHX
|
-531.22 | - | 3.77 % | $ 22.4 M | USA |
 |
Avenue Therapeutics
ATXI
|
-418.16 | - | -52.27 % | $ 4.45 M | USA |
 |
AIkido Pharma
AIKI
|
-36.89 | - | 1.93 % | $ 17.4 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - |  Russia |
 |
ARCA biopharma
ABIO
|
-21.9 | - | 1052.0 % | $ 415 M | USA |
 |
Acasti Pharma
ACST
|
-14.36 | - | 4.01 % | $ 150 M |  Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
-288.19 | - | -15.15 % | $ 60.3 M | Britain |
 |
BioNTech SE
BNTX
|
1.11 | $ 99.5 | -0.58 % | $ 27.2 B | Germany |
 |
BioDelivery Sciences International
BDSI
|
45.18 | - | -4.8 % | $ 255 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
21.78 | $ 28.01 | 2.47 % | $ 1.36 B | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-144.96 | $ 4.41 | -6.57 % | $ 9.6 B |  Israel |
 |
AVROBIO
AVRO
|
12.83 | - | 1083.1 % | $ 745 M | USA |
 |
Catalyst Biosciences
CBIO
|
540.06 | $ 11.04 | 0.91 % | $ 727 M | USA |
 |
BeiGene, Ltd.
BGNE
|
-19.35 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
CureVac N.V.
CVAC
|
-59.8 | - | - | $ 867 M | Germany |
 |
Acer Therapeutics
ACER
|
156.54 | - | 2.71 % | $ 14 M | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
114.5 | $ 11.09 | -5.62 % | $ 717 M | USA |
 |
BioVie
BIVI
|
-92.27 | $ 1.3 | -4.07 % | $ 1.92 M | USA |
 |
Axon Enterprise
AXON
|
16.2 | $ 617.73 | -0.51 % | $ 46.8 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
3458.87 | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
-71.51 | $ 2.66 | -6.01 % | $ 16.7 M | USA |
 |
AstraZeneca PLC
AZN
|
20.44 | $ 95.28 | 0.13 % | $ 96.9 B | Britain |
 |
Bellicum Pharmaceuticals
BLCM
|
-1239.35 | - | -9.72 % | $ 5.89 M | USA |
 |
Acorda Therapeutics
ACOR
|
160.08 | - | -24.86 % | $ 820 K | USA |
 |
Berkeley Lights
BLI
|
-69.02 | - | -7.31 % | $ 87 M | USA |
 |
Brickell Biotech
BBI
|
-57.34 | - | -5.38 % | $ 6.06 M | USA |
 |
Burford Capital Limited
BUR
|
10.1 | $ 9.28 | -0.16 % | $ 1.51 B | Britain |
 |
bluebird bio
BLUE
|
-108.93 | - | - | $ 546 M | USA |
 |
Biogen
BIIB
|
9.76 | $ 185.85 | -0.57 % | $ 27.1 B | USA |
 |
Abeona Therapeutics
ABEO
|
-365.49 | $ 5.06 | -3.07 % | $ 108 M | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
-123.35 | $ 1.46 | - | $ 16.7 M | Israel |
 |
Cellectis S.A.
CLLS
|
-26.25 | $ 4.5 | -1.1 % | $ 116 M | France |